Cited by 464Liver Diseases and ImmunityGenetic Associations and EpidemiologyInflammatory Bowel Disease

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

Open access
The UK PBC Consortium, Mells, George F, The Wellcome Trust Case Control Consortium 3, Floyd, James A B, Morley, Katherine I, Cordell, Heather J, Franklin, Christopher S, Shin, So-Youn +14 more·2011·Nature Genetics

Abstract

In addition to the HLA locus, six genetic risk factors for primary biliary cirrhosis (PBC) have been identified in recent genome-wide association studies (GWAS). To identify additional loci, we carried out a GWAS using 1,840 cases from the UK PBC Consortium and 5,163 UK population controls as part of the Wellcome Trust Case Control Consortium 3 (WTCCC3). We followed up 28 loci in an additional UK cohort of 620 PBC cases and 2,514 population controls. We identified 12 new susceptibility loci (at a genome-wide significance level of P < 5 × 10⁻⁸) and replicated all previously associated loci. We identified three further new loci in a meta-analysis of data from our study and previously published GWAS results. New candidate genes include STAT4, DENND1B, CD80, IL7R, CXCR5, TNFRSF1A, CLEC16A and NFKB1. This study has considerably expanded our knowledge of the genetic architecture of PBC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.789

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The presence of genetic susceptibility is supported by the increased concordance rate in monozygotic twins and confirmed by the identification of significant numbers of associated genetic loci in GWAS and other large-scale genetic approaches.

    “The presence of genetic susceptibility is supported by the increased concordance rate in monozygotic twins44 and confirmed by the identification of significant numbers of associated genetic loci in Genome Wide Association Studies (GWAS) and other large-scale, high-quality genetic approaches.45–54”
  • More than 60 non-HLA susceptibility regions have been identified in PBC pathogenesis.

    “In addition to the human leukocyte antigen (HLA) locus, more than 60 non-HLA susceptibility regions have been identified in PBC pathogenesis, including tumor necrosis factor superfamily member 15 (TNFSF15), Interleukin 12 A (IL12A), Interleukin 12 receptor (IL12R), Nuclear Factor Kappa B Subunit 1 (NFKB1) and other immune-associated genes6–11.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
The UK PBC Consortium, Mells, G. F., The Wellcome Trust Case Control Consortium 3, Floyd, J. A. B., Morley, K. I., Cordell, H. J., Franklin, C. S., Shin, S.-Y., Heneghan, M. A., Neuberger, J. M., Donaldson, P. T., Day, D. B., Ducker, S. J., Muriithi, A. W., Wheater, E. F., Hammond, C. J., Dawwas, M. F., Jones, D. E., Peltonen, L., Alexander, G. J., Sandford, R. N., & Anderson, C. A.
Affiliations
  • National Health Service (GB)
  • Wellcome Sanger Institute (GB)
  • The University of Melbourne (AU)
  • Newcastle University (GB)
  • Queen Elizabeth Hospital Birmingham (GB)
  • University of Cambridge (GB)
  • King's College London (GB)
Corresponding author
  • Sandford, Richard N
  • Anderson, Carl A
Venue
Nature Genetics
Published
2011-03-13
Volume
43
Issue
4
Pages
329-332
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W1965928933
Cited by
464
References
29
Citations by year
2026: 5 · 2025: 14 · 2024: 6 · 2023: 22 · 2022: 11 · 2021: 21 · 2020: 23 · 2019: 29 · 2018: 46 · 2017: 29 · 2016: 28 · 2015: 42 · 2014: 43 · 2013: 75 · 2012: 48
FWCI
37.82
Type
journal article
Language
en
Update notices
erratum (2011-10-27)
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eCommons - AKU (Aga Khan University) (submittedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Wellcome Trust (WT09355A/09/Z, WT090355/B/09/Z, WT090355/A/09/Z, WT91745/Z/10/Z, 085925/Z/08/Z, 091745)
  • National Institute for Health and Care Research
  • Isaac Newton Trust
  • U.S. Public Health Service (1R01LEY018246)
  • National Eye Institute (R01EY018246)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
Keywords
primary biliary cirrhosis, genetic susceptibility loci, genetic risk factors, HLA, STAT4, CD80, CD127, CXCR5, TNFRSF1A, CLEC16A, NFKB1, genetic architecture, autoimmune liver disease
MeSH terms
Female, Humans, Immunity, Innate, Liver Cirrhosis, Biliary, Male, Monosaccharide Transport Proteins, Risk Factors, Cohort Studies, Linkage Disequilibrium, Case-Control Studies, B7-1 Antigen, Genetic Predisposition to Disease, Receptors, Interleukin-7, Polymorphism, Single Nucleotide, Guanine Nucleotide Exchange Factors, Databases, Genetic, Lectins, C-Type, Receptors, Tumor Necrosis Factor, Type I, STAT4 Transcription Factor, NF-kappa B p50 Subunit, Death Domain Receptor Signaling Adaptor Proteins, Receptors, CXCR5, Genome-Wide Association Study, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review